Like it or not...........10 Dec 2021 09:14
.............I believe CF touched on the problem with the SP direction, albeit whilst presenting the opposing view, this company is STILL seen as a Covid share. Just look down the list of RNS's and most seem to relate to Covid related studies. It will only be through more large, non covid related studies (like today's) that the II's will be interested in jumping in to any noticeable effect, thus reversing the SP direction.